Form 4/A for ABBV AbbVie
Accepted 2023-05-09 00:00:00 ET · period of report 2023-02-17 · accession 0001415889-23-007667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-05-09 | 2023-02-17 | ABBV | AUSTIN ROXANNE S | Dir | S - Sale | $150.50 | -6,222 | 34.5K | -15% | -$936.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2023-02-17 | S | D | 6,222 | $150.50 | 34,483 | D | — | — |